| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Chemistry, Vol 42, 858-868, Copyright © 1996 by American Association for Clinical Chemistry
VE Velculescu and WS El-Deiry
The Johns Hopkins Oncology Center, Baltimore, MD 21231, USA.
The p53 tumor suppressor gene controls cellular growth after DNA damage through mechanisms involving growth arrest and apoptosis. Mutations that inactivate p53 occur commonly in virtually all human malignancies and can be detected by sequencing of the p53 gene, immunohistochemical staining of tumor tissue with anti-p53 antibodies, single-strand conformation polymorphisms, or other biological assays. Identification of p53 mutation in the germ line is diagnostic of the cancer-prone Li- Fraumeni syndrome. Alterations of the p53 gene result in defective cellular responses after DNA damage and predispose cells to dysregulated growth, tumor formation and progression, and potential resistance (of tumor cells) to certain chemotherapeutic agents or ionizing radiation. A variety of tumors involving mutant p53 have a worse prognosis than tumors of the same type containing no p53 mutations. New diagnostic and therapeutic strategies are evolving as the p53 pathways of cell-cycle arrest and apoptosis become elucidated.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  M. M.Y. Tin, C.-H. Cho, K. Chan, A. E. James, and J. K.S. Ko Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft Carcinogenesis, June 1, 2007; 28(6): 1347 - 1355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Menendez, A. Inga, J. Snipe, O. Krysiak, G. Schonfelder, and M. A. Resnick A Single-Nucleotide Polymorphism in a Half-Binding Site Creates p53 and Estrogen Receptor Control of Vascular Endothelial Growth Factor Receptor 1 Mol. Cell. Biol., April 1, 2007; 27(7): 2590 - 2600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kim, E. H. Kim, Y. W. Eom, W.-H. Kim, T. K. Kwon, S. J. Lee, and K. S. Choi Sulforaphane Sensitizes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Resistant Hepatoma Cells to TRAIL-Induced Apoptosis through Reactive Oxygen Species-Mediated Up-regulation of DR5 Cancer Res., February 1, 2006; 66(3): 1740 - 1750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Shiraishi, T. Yoshida, S. Nakata, M. Horinaka, M. Wakada, Y. Mizutani, T. Miki, and T. Sakai Tunicamycin Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Human Prostate Cancer Cells Cancer Res., July 15, 2005; 65(14): 6364 - 6370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Oh, J. Ju, B. C. Kim, E. Ko, B. J. Hong, J.-G. Park, J. W. Park, and K. Y. Choi DNA microarrays on a dendron-modified surface improve significantly the detection of single nucleotide variations in the p53 gene Nucleic Acids Res., June 6, 2005; 33(10): e90 - e90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Duffy Predictive Markers in Breast and Other Cancers: A Review Clin. Chem., March 1, 2005; 51(3): 494 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V. Biankin, A. L. Morey, C.-S. Lee, J. G. Kench, S. A. Biankin, H. C. Hook, D. R. Head, T. B. Hugh, R. L. Sutherland, and S. M. Henshall DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma J. Clin. Oncol., December 1, 2002; 20(23): 4531 - 4542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Biankin, J. G. Kench, A. L. Morey, C.-S. Lee, S. A. Biankin, D. R. Head, T. B. Hugh, S. M. Henshall, and R. L. Sutherland Overexpression of p21WAF1/CIP1 is an Early Event in the Development of Pancreatic Intraepithelial Neoplasia Cancer Res., December 1, 2001; 61(24): 8830 - 8837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Buschmann, O. Potapova, A. Bar-Shira, V. N. Ivanov, S. Y. Fuchs, S. Henderson, V. A. Fried, T. Minamoto, D. Alarcon-Vargas, M. R. Pincus, et al. Jun NH2-Terminal Kinase Phosphorylation of p53 on Thr-81 Is Important for p53 Stabilization and Transcriptional Activities in Response to Stress Mol. Cell. Biol., April 15, 2001; 21(8): 2743 - 2754. [Abstract] [Full Text]
|
|
|
|
|
|
Q. Zhu, G. Wani, M. A. Wani, and A. A. Wani Human Homologue of Yeast Rad23 Protein A Interacts with p300/Cyclic AMP-responsive Element Binding (CREB)-binding Protein to Down-Regulate Transcriptional Activity of p53 Cancer Res., January 1, 2001; 61(1): 64 - 70. [Abstract] [Full Text]
|
|
|
|
|
|
J. Rohayem, K. Conrad, T. Zimmermann, and K.-H. Frank Comparison of the Diagnostic Accuracy of Three Commercially Available Enzyme Immunoassays for Anti-p53 Antibodies Clin. Chem., November 1, 1999; 45(11): 2014 - 2016. [Full Text] [PDF]
|
|
|
|
 |
|
 C.-l. Huang, N. Kohno, H. Inufusa, K. Kodama, T. Taki, and M. Miyake Overexpression of bax Associated with Mutations in the Loop-Sheet-Helix Motif of p53 Am. J. Pathol., September 1, 1999; 155(3): 955 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Papp, H. Pemsel, R. Zimmermann, R. Bastrop, D. G Weiss, and D. Schiffmann Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi J. Med. Genet., August 1, 1999; 36(8): 610 - 614. [Abstract] [Full Text]
|
|
|
|
|
|
J. Wesierska-Gadek, Z.-Q. Wang, and G. Schmid Reduced Stability of Regularly Spliced but not Alternatively Spliced p53 Protein in PARP-deficient Mouse Fibroblasts Cancer Res., January 1, 1999; 59(1): 28 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. S. Bharaj, K. Angelopoulou, and E. P. Diamandis Rapid sequencing of the p53 gene with a new automated DNA sequencer Clin. Chem., July 1, 1998; 44(7): 1397 - 1403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ahmad, D. K. Feyes, R. Agarwal, and H. Mukhtar Photodynamic therapy results in induction of WAF1/CIP1/P21 leading to cell cycle arrest and apoptosis PNAS, June 9, 1998; 95(12): 6977 - 6982. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
